Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • Collaborative Medical Oncology Group (CMOG)
  • Medical Oncology Forum (MOF)
  • American Society of Clinical Oncology (ASCO)
  • Languages Spoken

  • Telugu
  • English
  • Hindi
  • Kannada
  • Tamil
  • Field of Expertise

  • Blood cancers (Acute lymphoblastic leukemia, Acute myeloid leukemia, chronic myeloid leukemia, Chronic lymphocytic leukemia), Plasma cell disorders
  • Autologous and Allogeneic stem cell transplants (matched sibling donor, matched/mismatched unrelated donor, haploidentical donor, cord blood transplants). Trained at Vancouver General Hospital, British Columbia that performs more than 300 stem cell transplants a year.
  • Childhood cancers
  • Immunotherapy
  • Targeted therapy
  • Awards & Achievements

  • University Topper (SDUAHER) Internal Medicine (2013).
  • 1st rank DM Medical Oncology Entrance Examination – Nizam’s Institute of Medical Sciences.
  • Oral presentation short-listed for the prestigious best of Annual American Society of Hematology Conference, San Diego, 2016
  • Best poster presentation award at ICON 2016
  • ICON 2017, Lucknow: Quiz (2nd Prize)
  • ISMPO-Torrent Young Scholar Award 2017, entered zonal round, Chennai.
  • Talks & Publications

  • Danthala M, Kallur KG, Prashant GR, Rajkumar K, Rao MR. 177 Lu-DOTATATE therapy in patients with neuroendocrine tumours: 5 years’ experience from a tertiary cancer care centre in India. European journal of nuclear medicine and molecular imaging. 2014 Jul 1;41(7):1319-26.
  • Danthala M, Gundeti S, Kuruva SP, Puligundla KC, Adusumilli P, Karnam AP, Bala S, Konatam ML, Maddali LS, Digumarti RR. Generic imatinib in chronic myeloid leukemia: survival of the cheapest. Clinical Lymphoma Myeloma and Leukemia. 2017 Jul 1;17(7):457-62.
  • Danthala M, Gundeti S, Maddali LS, Pillai A, Puligundla KC, Adusumilli RP. Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care center in India. South Asian journal of cancer. 2016 Oct;5(4):176.
  • Danthala M, Rajesh GR, Gundeti S, Raju GS, Chandran P, Srinivas ML. Obesity and breast cancer: Association of serum adiponectin, leptin, and adiponectin–leptin ratio as risk biomarkers. Indian Journal of Medical and Paediatric Oncology. 2018 Jul 1;39(3):292.
  • Danthala M, Lakshmaiah V. Correlative study of serum cystatin C levels with severity of acute ischemic stroke. Journal of Clinical and Biomedical Sciences J Clin Biomed Sci. 2013;3(4):188-92.
  • Karpurmath SV, Seshachalam A, Selvaraj K, Rajamani P, Reddy N, Malipatil B, Sirigeri R, Prasad K, Reddy K, Danthala M, Udupa KS. Halving time of BCR-ABL1 in Chronic Myeloid Leukemia, Is it a better than day 90 value–Multicenter study from south India. Clinical Lymphoma Myeloma and Leukemia. 2019 Sep 30.
  • Seshachalam A, Karpurmath SV, Rathnam K, Raman SG, Janarthinakani M, Prasad K, Patil C, Anoop P, Reddy N, Anumula SK, Roopa SP, Danthala M. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. Journal of global oncology. 2019 Dec;5:1-3.
  • Adusumilli P, Gundeti S, Danthala M, Pk C. 301P Long term survival and late side effects of paediatric Hodgkin lymphoma patients: a study from tertiary care centre in Southern India. Annals of Oncology. 2015 Dec 1;26(suppl_9):ix89-.
  • Puligundla CK, Gundeti S, Bala S, Pillai A, Adusumilli P, Danthala M, Konatam ML, Maddali LS. Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domain in CML Patients with Imatinib Treatment Failure-Data from a Large Tertiary Center in India. Blood 2016 vol: 128 (22) pp: 1910-1910.
  • Oral presentation/proffered paper: Additional chromosomal abnormalities in chronic myeloid leukemia: lest we forget. Presented at ESMO (European society of Medical Oncology) Asia 2016, Singapore.
  • Oral presentation: Generic Imatinib in Chronic Myeloid Leukemia: Survival of the cheapest. Presented at ASH 2016 (Annual American Society of Hematology conference), San Diego.
  • Paper presentation at KAPICON 2012 – “ Microalbuminuric Anemia “ – A Study of the relationship between Hemoglobin levels and Albuminuria in Diabetes.
  • Obesity and breast cancer: Association of serum adiponectin, leptin and adiponectin-leptin ratio as risk biomarkers. Presented at Annual Indian Society of Medical and Pediatric Oncology conference, 2016 at Delhi
  • Renal Reversibility in multiple myeloma: A race against the clock! Presented at Myeloma: State of the art, 2016, PGI Chandigarh
  • Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care centre in India. Presented at Annual Asian Clinical Oncology society conference 2016, Delhi
  • Validation of an enhanced International Prognostic Index (NCCN-IPI) in patients with diffuse large B cell lymphoma in the Rituximab era: 7 years’ experience from a tertiary care centre in South India. Presented at ICON 2016.
  • Frontline Imatinib in chronic myeloid leukemia: a jewel in the crown, Presented at Hematocon 2016, Jaipur
  • Pediatric chronic myeloid leukemia: wise to generalize? Presented at ISMPOCON 2016, Delhi
  • Poster presentation at HEMATOCON 2015 - Monosomy 7 and Deletion 7q in Acute Myeloid Leukemia – M0/M1 with prior Myelodysplastic syndrome transformed from Fanconi Anemia – a case report
  • Poster presentation at APICON 2013 (National Conference) - Phenytoin induced Cerebellar Ataxia and Orofacial Dyskinesia in a rare case of Disseminated Cysticercosis.
  • Manipal Hospitals Vijayawada: Dr Madhav Danthala & Team successfully performed RARE HAPLOIDENTICAL BONE MARROW TRANSPLANT SURGERY extensively covered in media. Click Here

    Languages Spoken

  • Telugu
  • English
  • Hindi
  • Kannada
  • Tamil
  • Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • Collaborative Medical Oncology Group (CMOG)
  • Medical Oncology Forum (MOF)
  • American Society of Clinical Oncology (ASCO)
  • Field of Expertise

  • Blood cancers (Acute lymphoblastic leukemia, Acute myeloid leukemia, chronic myeloid leukemia, Chronic lymphocytic leukemia), Plasma cell disorders
  • Autologous and Allogeneic stem cell transplants (matched sibling donor, matched/mismatched unrelated donor, haploidentical donor, cord blood transplants). Trained at Vancouver General Hospital, British Columbia that performs more than 300 stem cell transplants a year.
  • Childhood cancers
  • Immunotherapy
  • Targeted therapy
  • Awards & Achievements

  • University Topper (SDUAHER) Internal Medicine (2013).
  • 1st rank DM Medical Oncology Entrance Examination – Nizam’s Institute of Medical Sciences.
  • Oral presentation short-listed for the prestigious best of Annual American Society of Hematology Conference, San Diego, 2016
  • Best poster presentation award at ICON 2016
  • ICON 2017, Lucknow: Quiz (2nd Prize)
  • ISMPO-Torrent Young Scholar Award 2017, entered zonal round, Chennai.
  • Talks & Publications

  • Danthala M, Kallur KG, Prashant GR, Rajkumar K, Rao MR. 177 Lu-DOTATATE therapy in patients with neuroendocrine tumours: 5 years’ experience from a tertiary cancer care centre in India. European journal of nuclear medicine and molecular imaging. 2014 Jul 1;41(7):1319-26.
  • Danthala M, Gundeti S, Kuruva SP, Puligundla KC, Adusumilli P, Karnam AP, Bala S, Konatam ML, Maddali LS, Digumarti RR. Generic imatinib in chronic myeloid leukemia: survival of the cheapest. Clinical Lymphoma Myeloma and Leukemia. 2017 Jul 1;17(7):457-62.
  • Danthala M, Gundeti S, Maddali LS, Pillai A, Puligundla KC, Adusumilli RP. Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care center in India. South Asian journal of cancer. 2016 Oct;5(4):176.
  • Danthala M, Rajesh GR, Gundeti S, Raju GS, Chandran P, Srinivas ML. Obesity and breast cancer: Association of serum adiponectin, leptin, and adiponectin–leptin ratio as risk biomarkers. Indian Journal of Medical and Paediatric Oncology. 2018 Jul 1;39(3):292.
  • Danthala M, Lakshmaiah V. Correlative study of serum cystatin C levels with severity of acute ischemic stroke. Journal of Clinical and Biomedical Sciences J Clin Biomed Sci. 2013;3(4):188-92.
  • Karpurmath SV, Seshachalam A, Selvaraj K, Rajamani P, Reddy N, Malipatil B, Sirigeri R, Prasad K, Reddy K, Danthala M, Udupa KS. Halving time of BCR-ABL1 in Chronic Myeloid Leukemia, Is it a better than day 90 value–Multicenter study from south India. Clinical Lymphoma Myeloma and Leukemia. 2019 Sep 30.
  • Seshachalam A, Karpurmath SV, Rathnam K, Raman SG, Janarthinakani M, Prasad K, Patil C, Anoop P, Reddy N, Anumula SK, Roopa SP, Danthala M. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. Journal of global oncology. 2019 Dec;5:1-3.
  • Adusumilli P, Gundeti S, Danthala M, Pk C. 301P Long term survival and late side effects of paediatric Hodgkin lymphoma patients: a study from tertiary care centre in Southern India. Annals of Oncology. 2015 Dec 1;26(suppl_9):ix89-.
  • Puligundla CK, Gundeti S, Bala S, Pillai A, Adusumilli P, Danthala M, Konatam ML, Maddali LS. Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domain in CML Patients with Imatinib Treatment Failure-Data from a Large Tertiary Center in India. Blood 2016 vol: 128 (22) pp: 1910-1910.
  • Oral presentation/proffered paper: Additional chromosomal abnormalities in chronic myeloid leukemia: lest we forget. Presented at ESMO (European society of Medical Oncology) Asia 2016, Singapore.
  • Oral presentation: Generic Imatinib in Chronic Myeloid Leukemia: Survival of the cheapest. Presented at ASH 2016 (Annual American Society of Hematology conference), San Diego.
  • Paper presentation at KAPICON 2012 – “ Microalbuminuric Anemia “ – A Study of the relationship between Hemoglobin levels and Albuminuria in Diabetes.
  • Obesity and breast cancer: Association of serum adiponectin, leptin and adiponectin-leptin ratio as risk biomarkers. Presented at Annual Indian Society of Medical and Pediatric Oncology conference, 2016 at Delhi
  • Renal Reversibility in multiple myeloma: A race against the clock! Presented at Myeloma: State of the art, 2016, PGI Chandigarh
  • Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care centre in India. Presented at Annual Asian Clinical Oncology society conference 2016, Delhi
  • Validation of an enhanced International Prognostic Index (NCCN-IPI) in patients with diffuse large B cell lymphoma in the Rituximab era: 7 years’ experience from a tertiary care centre in South India. Presented at ICON 2016.
  • Frontline Imatinib in chronic myeloid leukemia: a jewel in the crown, Presented at Hematocon 2016, Jaipur
  • Pediatric chronic myeloid leukemia: wise to generalize? Presented at ISMPOCON 2016, Delhi
  • Poster presentation at HEMATOCON 2015 - Monosomy 7 and Deletion 7q in Acute Myeloid Leukemia – M0/M1 with prior Myelodysplastic syndrome transformed from Fanconi Anemia – a case report
  • Poster presentation at APICON 2013 (National Conference) - Phenytoin induced Cerebellar Ataxia and Orofacial Dyskinesia in a rare case of Disseminated Cysticercosis.
  • Manipal Hospitals Vijayawada: Dr Madhav Danthala & Team successfully performed RARE HAPLOIDENTICAL BONE MARROW TRANSPLANT SURGERY extensively covered in media. Click Here

    Field of Expertise

  • Blood cancers (Acute lymphoblastic leukemia, Acute myeloid leukemia, chronic myeloid leukemia, Chronic lymphocytic leukemia), Plasma cell disorders
  • Autologous and Allogeneic stem cell transplants (matched sibling donor, matched/mismatched unrelated donor, haploidentical donor, cord blood transplants). Trained at Vancouver General Hospital, British Columbia that performs more than 300 stem cell transplants a year.
  • Childhood cancers
  • Immunotherapy
  • Targeted therapy
  • Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • Collaborative Medical Oncology Group (CMOG)
  • Medical Oncology Forum (MOF)
  • American Society of Clinical Oncology (ASCO)
  • Languages Spoken

  • Telugu
  • English
  • Hindi
  • Kannada
  • Tamil
  • Awards & Achievements

  • University Topper (SDUAHER) Internal Medicine (2013).
  • 1st rank DM Medical Oncology Entrance Examination – Nizam’s Institute of Medical Sciences.
  • Oral presentation short-listed for the prestigious best of Annual American Society of Hematology Conference, San Diego, 2016
  • Best poster presentation award at ICON 2016
  • ICON 2017, Lucknow: Quiz (2nd Prize)
  • ISMPO-Torrent Young Scholar Award 2017, entered zonal round, Chennai.
  • Talks & Publications

  • Danthala M, Kallur KG, Prashant GR, Rajkumar K, Rao MR. 177 Lu-DOTATATE therapy in patients with neuroendocrine tumours: 5 years’ experience from a tertiary cancer care centre in India. European journal of nuclear medicine and molecular imaging. 2014 Jul 1;41(7):1319-26.
  • Danthala M, Gundeti S, Kuruva SP, Puligundla KC, Adusumilli P, Karnam AP, Bala S, Konatam ML, Maddali LS, Digumarti RR. Generic imatinib in chronic myeloid leukemia: survival of the cheapest. Clinical Lymphoma Myeloma and Leukemia. 2017 Jul 1;17(7):457-62.
  • Danthala M, Gundeti S, Maddali LS, Pillai A, Puligundla KC, Adusumilli RP. Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care center in India. South Asian journal of cancer. 2016 Oct;5(4):176.
  • Danthala M, Rajesh GR, Gundeti S, Raju GS, Chandran P, Srinivas ML. Obesity and breast cancer: Association of serum adiponectin, leptin, and adiponectin–leptin ratio as risk biomarkers. Indian Journal of Medical and Paediatric Oncology. 2018 Jul 1;39(3):292.
  • Danthala M, Lakshmaiah V. Correlative study of serum cystatin C levels with severity of acute ischemic stroke. Journal of Clinical and Biomedical Sciences J Clin Biomed Sci. 2013;3(4):188-92.
  • Karpurmath SV, Seshachalam A, Selvaraj K, Rajamani P, Reddy N, Malipatil B, Sirigeri R, Prasad K, Reddy K, Danthala M, Udupa KS. Halving time of BCR-ABL1 in Chronic Myeloid Leukemia, Is it a better than day 90 value–Multicenter study from south India. Clinical Lymphoma Myeloma and Leukemia. 2019 Sep 30.
  • Seshachalam A, Karpurmath SV, Rathnam K, Raman SG, Janarthinakani M, Prasad K, Patil C, Anoop P, Reddy N, Anumula SK, Roopa SP, Danthala M. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. Journal of global oncology. 2019 Dec;5:1-3.
  • Adusumilli P, Gundeti S, Danthala M, Pk C. 301P Long term survival and late side effects of paediatric Hodgkin lymphoma patients: a study from tertiary care centre in Southern India. Annals of Oncology. 2015 Dec 1;26(suppl_9):ix89-.
  • Puligundla CK, Gundeti S, Bala S, Pillai A, Adusumilli P, Danthala M, Konatam ML, Maddali LS. Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domain in CML Patients with Imatinib Treatment Failure-Data from a Large Tertiary Center in India. Blood 2016 vol: 128 (22) pp: 1910-1910.
  • Oral presentation/proffered paper: Additional chromosomal abnormalities in chronic myeloid leukemia: lest we forget. Presented at ESMO (European society of Medical Oncology) Asia 2016, Singapore.
  • Oral presentation: Generic Imatinib in Chronic Myeloid Leukemia: Survival of the cheapest. Presented at ASH 2016 (Annual American Society of Hematology conference), San Diego.
  • Paper presentation at KAPICON 2012 – “ Microalbuminuric Anemia “ – A Study of the relationship between Hemoglobin levels and Albuminuria in Diabetes.
  • Obesity and breast cancer: Association of serum adiponectin, leptin and adiponectin-leptin ratio as risk biomarkers. Presented at Annual Indian Society of Medical and Pediatric Oncology conference, 2016 at Delhi
  • Renal Reversibility in multiple myeloma: A race against the clock! Presented at Myeloma: State of the art, 2016, PGI Chandigarh
  • Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care centre in India. Presented at Annual Asian Clinical Oncology society conference 2016, Delhi
  • Validation of an enhanced International Prognostic Index (NCCN-IPI) in patients with diffuse large B cell lymphoma in the Rituximab era: 7 years’ experience from a tertiary care centre in South India. Presented at ICON 2016.
  • Frontline Imatinib in chronic myeloid leukemia: a jewel in the crown, Presented at Hematocon 2016, Jaipur
  • Pediatric chronic myeloid leukemia: wise to generalize? Presented at ISMPOCON 2016, Delhi
  • Poster presentation at HEMATOCON 2015 - Monosomy 7 and Deletion 7q in Acute Myeloid Leukemia – M0/M1 with prior Myelodysplastic syndrome transformed from Fanconi Anemia – a case report
  • Poster presentation at APICON 2013 (National Conference) - Phenytoin induced Cerebellar Ataxia and Orofacial Dyskinesia in a rare case of Disseminated Cysticercosis.
  • Manipal Hospitals Vijayawada: Dr Madhav Danthala & Team successfully performed RARE HAPLOIDENTICAL BONE MARROW TRANSPLANT SURGERY extensively covered in media. Click Here

    Awards & Achievements

  • University Topper (SDUAHER) Internal Medicine (2013).
  • 1st rank DM Medical Oncology Entrance Examination – Nizam’s Institute of Medical Sciences.
  • Oral presentation short-listed for the prestigious best of Annual American Society of Hematology Conference, San Diego, 2016
  • Best poster presentation award at ICON 2016
  • ICON 2017, Lucknow: Quiz (2nd Prize)
  • ISMPO-Torrent Young Scholar Award 2017, entered zonal round, Chennai.
  • Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • Collaborative Medical Oncology Group (CMOG)
  • Medical Oncology Forum (MOF)
  • American Society of Clinical Oncology (ASCO)
  • Languages Spoken

  • Telugu
  • English
  • Hindi
  • Kannada
  • Tamil
  • Field of Expertise

  • Blood cancers (Acute lymphoblastic leukemia, Acute myeloid leukemia, chronic myeloid leukemia, Chronic lymphocytic leukemia), Plasma cell disorders
  • Autologous and Allogeneic stem cell transplants (matched sibling donor, matched/mismatched unrelated donor, haploidentical donor, cord blood transplants). Trained at Vancouver General Hospital, British Columbia that performs more than 300 stem cell transplants a year.
  • Childhood cancers
  • Immunotherapy
  • Targeted therapy
  • Talks & Publications

  • Danthala M, Kallur KG, Prashant GR, Rajkumar K, Rao MR. 177 Lu-DOTATATE therapy in patients with neuroendocrine tumours: 5 years’ experience from a tertiary cancer care centre in India. European journal of nuclear medicine and molecular imaging. 2014 Jul 1;41(7):1319-26.
  • Danthala M, Gundeti S, Kuruva SP, Puligundla KC, Adusumilli P, Karnam AP, Bala S, Konatam ML, Maddali LS, Digumarti RR. Generic imatinib in chronic myeloid leukemia: survival of the cheapest. Clinical Lymphoma Myeloma and Leukemia. 2017 Jul 1;17(7):457-62.
  • Danthala M, Gundeti S, Maddali LS, Pillai A, Puligundla KC, Adusumilli RP. Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care center in India. South Asian journal of cancer. 2016 Oct;5(4):176.
  • Danthala M, Rajesh GR, Gundeti S, Raju GS, Chandran P, Srinivas ML. Obesity and breast cancer: Association of serum adiponectin, leptin, and adiponectin–leptin ratio as risk biomarkers. Indian Journal of Medical and Paediatric Oncology. 2018 Jul 1;39(3):292.
  • Danthala M, Lakshmaiah V. Correlative study of serum cystatin C levels with severity of acute ischemic stroke. Journal of Clinical and Biomedical Sciences J Clin Biomed Sci. 2013;3(4):188-92.
  • Karpurmath SV, Seshachalam A, Selvaraj K, Rajamani P, Reddy N, Malipatil B, Sirigeri R, Prasad K, Reddy K, Danthala M, Udupa KS. Halving time of BCR-ABL1 in Chronic Myeloid Leukemia, Is it a better than day 90 value–Multicenter study from south India. Clinical Lymphoma Myeloma and Leukemia. 2019 Sep 30.
  • Seshachalam A, Karpurmath SV, Rathnam K, Raman SG, Janarthinakani M, Prasad K, Patil C, Anoop P, Reddy N, Anumula SK, Roopa SP, Danthala M. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. Journal of global oncology. 2019 Dec;5:1-3.
  • Adusumilli P, Gundeti S, Danthala M, Pk C. 301P Long term survival and late side effects of paediatric Hodgkin lymphoma patients: a study from tertiary care centre in Southern India. Annals of Oncology. 2015 Dec 1;26(suppl_9):ix89-.
  • Puligundla CK, Gundeti S, Bala S, Pillai A, Adusumilli P, Danthala M, Konatam ML, Maddali LS. Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domain in CML Patients with Imatinib Treatment Failure-Data from a Large Tertiary Center in India. Blood 2016 vol: 128 (22) pp: 1910-1910.
  • Oral presentation/proffered paper: Additional chromosomal abnormalities in chronic myeloid leukemia: lest we forget. Presented at ESMO (European society of Medical Oncology) Asia 2016, Singapore.
  • Oral presentation: Generic Imatinib in Chronic Myeloid Leukemia: Survival of the cheapest. Presented at ASH 2016 (Annual American Society of Hematology conference), San Diego.
  • Paper presentation at KAPICON 2012 – “ Microalbuminuric Anemia “ – A Study of the relationship between Hemoglobin levels and Albuminuria in Diabetes.
  • Obesity and breast cancer: Association of serum adiponectin, leptin and adiponectin-leptin ratio as risk biomarkers. Presented at Annual Indian Society of Medical and Pediatric Oncology conference, 2016 at Delhi
  • Renal Reversibility in multiple myeloma: A race against the clock! Presented at Myeloma: State of the art, 2016, PGI Chandigarh
  • Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care centre in India. Presented at Annual Asian Clinical Oncology society conference 2016, Delhi
  • Validation of an enhanced International Prognostic Index (NCCN-IPI) in patients with diffuse large B cell lymphoma in the Rituximab era: 7 years’ experience from a tertiary care centre in South India. Presented at ICON 2016.
  • Frontline Imatinib in chronic myeloid leukemia: a jewel in the crown, Presented at Hematocon 2016, Jaipur
  • Pediatric chronic myeloid leukemia: wise to generalize? Presented at ISMPOCON 2016, Delhi
  • Poster presentation at HEMATOCON 2015 - Monosomy 7 and Deletion 7q in Acute Myeloid Leukemia – M0/M1 with prior Myelodysplastic syndrome transformed from Fanconi Anemia – a case report
  • Poster presentation at APICON 2013 (National Conference) - Phenytoin induced Cerebellar Ataxia and Orofacial Dyskinesia in a rare case of Disseminated Cysticercosis.
  • Manipal Hospitals Vijayawada: Dr Madhav Danthala & Team successfully performed RARE HAPLOIDENTICAL BONE MARROW TRANSPLANT SURGERY extensively covered in media. Click Here

    Talks & Publications

  • Danthala M, Kallur KG, Prashant GR, Rajkumar K, Rao MR. 177 Lu-DOTATATE therapy in patients with neuroendocrine tumours: 5 years’ experience from a tertiary cancer care centre in India. European journal of nuclear medicine and molecular imaging. 2014 Jul 1;41(7):1319-26.
  • Danthala M, Gundeti S, Kuruva SP, Puligundla KC, Adusumilli P, Karnam AP, Bala S, Konatam ML, Maddali LS, Digumarti RR. Generic imatinib in chronic myeloid leukemia: survival of the cheapest. Clinical Lymphoma Myeloma and Leukemia. 2017 Jul 1;17(7):457-62.
  • Danthala M, Gundeti S, Maddali LS, Pillai A, Puligundla KC, Adusumilli RP. Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care center in India. South Asian journal of cancer. 2016 Oct;5(4):176.
  • Danthala M, Rajesh GR, Gundeti S, Raju GS, Chandran P, Srinivas ML. Obesity and breast cancer: Association of serum adiponectin, leptin, and adiponectin–leptin ratio as risk biomarkers. Indian Journal of Medical and Paediatric Oncology. 2018 Jul 1;39(3):292.
  • Danthala M, Lakshmaiah V. Correlative study of serum cystatin C levels with severity of acute ischemic stroke. Journal of Clinical and Biomedical Sciences J Clin Biomed Sci. 2013;3(4):188-92.
  • Karpurmath SV, Seshachalam A, Selvaraj K, Rajamani P, Reddy N, Malipatil B, Sirigeri R, Prasad K, Reddy K, Danthala M, Udupa KS. Halving time of BCR-ABL1 in Chronic Myeloid Leukemia, Is it a better than day 90 value–Multicenter study from south India. Clinical Lymphoma Myeloma and Leukemia. 2019 Sep 30.
  • Seshachalam A, Karpurmath SV, Rathnam K, Raman SG, Janarthinakani M, Prasad K, Patil C, Anoop P, Reddy N, Anumula SK, Roopa SP, Danthala M. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. Journal of global oncology. 2019 Dec;5:1-3.
  • Adusumilli P, Gundeti S, Danthala M, Pk C. 301P Long term survival and late side effects of paediatric Hodgkin lymphoma patients: a study from tertiary care centre in Southern India. Annals of Oncology. 2015 Dec 1;26(suppl_9):ix89-.
  • Puligundla CK, Gundeti S, Bala S, Pillai A, Adusumilli P, Danthala M, Konatam ML, Maddali LS. Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domain in CML Patients with Imatinib Treatment Failure-Data from a Large Tertiary Center in India. Blood 2016 vol: 128 (22) pp: 1910-1910.
  • Oral presentation/proffered paper: Additional chromosomal abnormalities in chronic myeloid leukemia: lest we forget. Presented at ESMO (European society of Medical Oncology) Asia 2016, Singapore.
  • Oral presentation: Generic Imatinib in Chronic Myeloid Leukemia: Survival of the cheapest. Presented at ASH 2016 (Annual American Society of Hematology conference), San Diego.
  • Paper presentation at KAPICON 2012 – “ Microalbuminuric Anemia “ – A Study of the relationship between Hemoglobin levels and Albuminuria in Diabetes.
  • Obesity and breast cancer: Association of serum adiponectin, leptin and adiponectin-leptin ratio as risk biomarkers. Presented at Annual Indian Society of Medical and Pediatric Oncology conference, 2016 at Delhi
  • Renal Reversibility in multiple myeloma: A race against the clock! Presented at Myeloma: State of the art, 2016, PGI Chandigarh
  • Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care centre in India. Presented at Annual Asian Clinical Oncology society conference 2016, Delhi
  • Validation of an enhanced International Prognostic Index (NCCN-IPI) in patients with diffuse large B cell lymphoma in the Rituximab era: 7 years’ experience from a tertiary care centre in South India. Presented at ICON 2016.
  • Frontline Imatinib in chronic myeloid leukemia: a jewel in the crown, Presented at Hematocon 2016, Jaipur
  • Pediatric chronic myeloid leukemia: wise to generalize? Presented at ISMPOCON 2016, Delhi
  • Poster presentation at HEMATOCON 2015 - Monosomy 7 and Deletion 7q in Acute Myeloid Leukemia – M0/M1 with prior Myelodysplastic syndrome transformed from Fanconi Anemia – a case report
  • Poster presentation at APICON 2013 (National Conference) - Phenytoin induced Cerebellar Ataxia and Orofacial Dyskinesia in a rare case of Disseminated Cysticercosis.
  • Manipal Hospitals Vijayawada: Dr Madhav Danthala & Team successfully performed RARE HAPLOIDENTICAL BONE MARROW TRANSPLANT SURGERY extensively covered in media. Click Here
  • Awards & Achievements

  • University Topper (SDUAHER) Internal Medicine (2013).
  • 1st rank DM Medical Oncology Entrance Examination – Nizam’s Institute of Medical Sciences.
  • Oral presentation short-listed for the prestigious best of Annual American Society of Hematology Conference, San Diego, 2016
  • Best poster presentation award at ICON 2016
  • ICON 2017, Lucknow: Quiz (2nd Prize)
  • ISMPO-Torrent Young Scholar Award 2017, entered zonal round, Chennai.
  • Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • Collaborative Medical Oncology Group (CMOG)
  • Medical Oncology Forum (MOF)
  • American Society of Clinical Oncology (ASCO)
  • Languages Spoken

  • Telugu
  • English
  • Hindi
  • Kannada
  • Tamil
  • Field of Expertise

  • Blood cancers (Acute lymphoblastic leukemia, Acute myeloid leukemia, chronic myeloid leukemia, Chronic lymphocytic leukemia), Plasma cell disorders
  • Autologous and Allogeneic stem cell transplants (matched sibling donor, matched/mismatched unrelated donor, haploidentical donor, cord blood transplants). Trained at Vancouver General Hospital, British Columbia that performs more than 300 stem cell transplants a year.
  • Childhood cancers
  • Immunotherapy
  • Targeted therapy

Blogs

Homecare icon Appointment
Homecare icon Health Check
Contact Us
Write to COO
Call Us